key: cord-0906833-9017kdo1
authors: Sridhar, Sushmita; Turbett, Sarah E.; Harris, Jason B.; LaRocque, Regina C.
title: Antimicrobial-resistant bacteria in international travelers
date: 2021-07-15
journal: Curr Opin Infect Dis
DOI: 10.1097/qco.0000000000000751
sha: fbbd27fcfec12a6ebc7fd959db7c4987719cfdae
doc_id: 906833
cord_uid: 9017kdo1

PURPOSE OF REVIEW: Antimicrobial resistance (AMR) in bacteria poses a major risk to global public health, with many factors contributing to the observed increase in AMR. International travel is one recognized contributor. The purpose of this review is to summarize current knowledge regarding the acquisition, carriage and spread of AMR bacteria by international travelers. RECENT FINDINGS: Recent studies have highlighted that travel is an important risk factor for the acquisition of AMR bacteria, with approximately 30% of studied travelers returning with an acquired AMR bacterium. Epidemiological studies have shown there are three major risk factors for acquisition: travel destination, antimicrobial usage and travelers’ diarrhea (TD). Analyses have begun to illustrate the AMR genes that are acquired and spread by travelers, risk factors for acquisition and carriage of AMR bacteria, and local transmission of imported AMR organisms. SUMMARY: International travel is a contributor to the acquisition and dissemination of AMR organisms globally. Efforts to reduce the burden of AMR organisms should include a focus on international travelers. Routine genomic surveillance would further elucidate the role of international travel in the global spread of AMR bacteria.

Antimicrobial resistance (AMR) is a global public health threat, and its frequency is increasing [1] [2] [3] . AMR is directly correlated with antimicrobial usage, and its spread is driven by the transfer of resistant organisms and resistance genes between humans, other animals and the environment [4] . Recent models have suggested that without intervention, deaths attributable to AMR may reach 10 million by 2050, with disproportionate effects on individuals in low and middle-income countries (LMIC) [1, 2] . This problem is compounded by the lack of novel antimicrobials and vaccines for many bacterial infections, and by high and inappropriate antimicrobial usage in many parts of the world, driving variable geographic patterns of AMR [1, 3] The heavy use of antimicrobials for livestock, aquaculture and in routine clinical practice, and the environmental accumulation of antimicrobials through runoff, are widely recognized as important contributing factors in the rise of AMR [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . As a result, there has been a steady increase in resistance, especially among gram-negative bacteria, to important classes of antimicrobials, including beta-lactams, fluoroquinolones and polymyxins [8, 17, 18] . The carriage of extended spectrum beta-lactamase (ESBL)-producing bacteria among healthy individuals has increased by 5% each year between 1978 and 2015 [19] .

International travel has been identified as playing a role in the spread of resistance genes and

Except for the slowdown associated with the COVID-19 pandemic, international travel has been steadily increasing for decades. In 2019, there were 1.46 billion international tourist arrivals, representing an increase of 4% from the previous year [23] . This overall increase in travel has been paired with a concomitant increase in travel to and between countries with vulnerable health systems and inadequate public health infrastructure, as assessed by the Fragile States Index (FSI) [ 

Most studies of AMR in travelers have been small convenience cohorts. To date, a small set of published studies have enrolled a sizable number (i.e. more than 100) of international travelers and have systematically characterized the acquisition of AMR bacteria in these cohorts (Table 1) . All have focused on the acquisition of ESBL-producing gram-negative bacteria. More recent studies have assessed the presence of additional resistance genes, including those associated with carbapenem resistance and mcrmediated colistin resistance. Here, we summarize the findings of seven large studies that have conducted recent analyses (Table 1) The VOYAG-R study prospectively followed 574 French international travelers between 2012 and 2013 longitudinally up to 12 months, sampling stool pretravel and posttravel at 1, 2, 3, 6 and 12 months for ESBL-PE, CPE and plasmid-mediated AmpC (pAmpC)-type cephalosporinases [32, 33] . The top travel regions were Asia, sub-Saharan Africa and Latin America, and 51% of travelers acquired an AMR organism, 92% of which were ESBL-PE, and which were predominantly E. coli. There was independent and concomitant pAmpC production, and three instances of CPE. There was a 16% carriage rate of travel-acquired bacteria after 1 month, which halved over each subsequent follow-up interval. A more recent analysis of 43 participants in the

Antimicrobial resistance is growing rapidly globally.

Approximately 30% of international travelers acquire ESBL-PE during travel; these are predominantly E. coli and often carry resistance to multiple antimicrobials.

Risk factors for AMR bacterial acquisition include travel destination, antimicrobial usage and travelers' diarrhea.

Substantial efforts are needed to address the increase in AMR associated with travel, and these efforts should prioritize genomic surveillance and improved antimicrobial stewardship in travelers. ESBL-P, CP-CR, pAmpC production, and MCR were the only resistance profiles phenotypically measured; ESBL-P, extended-spectrum beta-lactamase-producing; CP-CR, carbapenemase-producing carbapenem-resistant; MCR, mcr-mediated colistin-resistant; PMQR, plasmid-mediated quinolone resistance.

VOYAG-R cohort investigated microbiota composition pre and posttravel, finding that diarrhea during travel was associated with a higher abundance of ].

Overall, although there are some differences between these traveler cohort studies, there are clear trends indicating that ESBL-PE acquisition occurs in approximately 30% of travelers. The most recent studies have also observed acquisition of CPE and MCRE. These findings suggest continued evolution of AMR and an increase in circulating resistance genes, which may be readily acquired and transmitted by travelers.

Antimicrobial usage, travelers' diarrhea and destination have been repeatedly identified as risk factors for AMR bacterial acquisition during travel (Fig. 1 

Multidrug-resistant typhoidal and paratyphoid Salmonella enterica are a special concern with regard to international travel. Two recent studies have investigated travel-associated enteric fever. There were 68 reported cases of imported ESBL Salmonella Typhi and Salmonella Paratyphi in the UK between 2017 and 2020 [56 & ]. The majority of cases were associated with travel to Pakistan, where there is an ongoing outbreak of extremely drug-resistant S. Typhi in the Sindh province [57, 58] . A separate multisite study of travelers with enteric fever found that 65% of S. Typhi isolates were resistant to multiple classes of antimicrobials [50 && ]. Of the infected travelers, 59% (522/888) required hospitalization; in children, the rate of hospitalization was 61%. Of the surveyed travelers with S. Typhi (70 travelers), only 10% had received a typhoid fever vaccine. Interestingly, typhoid fever was more common in travelers visiting friends and relatives, whereas paratyphoid fever was more common in leisure travelers [50 && ].

Many gaps remain in our understanding of travelassociated AMR. The breakdown in regular healthcare due to COVID-19 may have exacerbated AMR challenges, and this lends urgency to increased efforts to monitor and combat AMR [59] . Here, we highlight four areas in need of further investigation and development.

Recent work has indicated there may be transmission of ESBL Enterobacterales from travelers to previously uncolonized household members, and further genomic investigations could confirm such links [30] . There has also been evidence of secondary transmission of Shigella spp. and E. coli in the Netherlands with genomic similarity to travel-associated clusters [60 & ]. Many studies have tracked the spread of New Delhi metallo-beta-lactamase 1 (NDM-1) and more recently the dissemination of mcr-1, showing that these resistance elements have spread geographically and become endemic in some parts of the world [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] . One recent example of this is nearly identical plasmids with blaNDM-5 and qepA in E. coli found in Pakistan and Canada [73] . Existing efforts to follow AMR and specific pathogens include GeoSentinel, NARMS and Pathogen-Watch, and such efforts could be implemented more broadly [50 && , [74] [75] [76] [77] . New genomic surveillance efforts have been implemented during the COVID-19 pandemic, and prioritizing the development and support for such infrastructure is crucial for global AMR control efforts as well [78] [79] [80] .

Another gap in understanding is how the gut microbiome influences and is influenced by travel-associated AMR. ESBL Enterobacterales acquisition and carriage have been shown to be temporal and highly dynamic, but it is unclear what the ramifications of that are for gut microbial communities and risk of infection [45 & ]. There is some evidence that Actinobacteria species richness pretravel lowers the risk of ESBL-E acquisition during travel, and the VOYAG-R study found that higher abundance of Prevotella species is correlated with during-travel diarrhea; further studies would be valuable in determining the relationship between the gut microbiome and travel-associated AMR ]. In addition, past traveller studies have been biased in sampling primarily European and American travelers. Analyzing more diverse populations and samples will provide greater insight into AMR patterns.

Travel-associated AMR has implications for clinical practice. Medical practitioners should be aware of travel history as a risk factor for AMR. Clinicians providing pretravel health consultation should also consider antimicrobial stewardship principles and be cautious about the prescription of broad-spectrum antimicrobials for empiric use by travelers. Recent analyses have shown that although the occurrence of travelers' diarrhea cannot be controlled for, reducing the use of empiric antimicrobial treatment for travelers' diarrhea may be useful for lowering the acquisition of travel-associated AMR bacteria [21 & ,55 && ,82].

Research over the past decade has shown that approximately 30% of international travelers acquire AMR bacteria during travel, indicating that international travel is one component of the global problem of AMR. Surveillance, antimicrobial stewardship in travelers and novel strategies to decrease AMR acquisition by international travelers are essential for mitigating the global spread of AMR.

None. This work was supported by the US Centers for Disease Control and Prevention (U01 CK000490) and the National Institutes of Health (R01AI137164 and R01AI099243).

There are no conflicts of interest.

Papers of particular interest, published within the annual period of review, have been highlighted as:

Kantele A, Laaveri T. Extended-spectrum beta-lactamase-producing strains among diarrheagenic Escherichia coli-prospective traveler study with literature review. J Travel Med 2021; 1-13. This study analyzes diarrheagenic E. coli found within Finnish international travelers, finding that 2.7% of DEC were ESBL-producing, and there was concomitant resistance to other antimicrobials. This study looks at the acquisition of specific organisms in a cohort of French medical students traveling abroad. In particular, they discuss EAEC and EPEC acquisition. They also find that there are within-region differences in AMR genes and acquisition, and that association with orphanages is a significant risk factor. 39. Dao TL, Gautret P. Patterns of diseases in health students abroad: a systematic review. This cross-sectional multisite study evaluates enteric fever incidence and AMR in 889 returned international travelers, finding high levels of fluoroquinolone resistance. They use data from the GeoSentinel surveillance study, and they find that most infections occur when travelers visit friends and relatives in South Asia.

Buchek G, Mende K, Telu K, et al. Travel-associated multidrug-resistant organism acquisition and risk factors among US military personnel. J Travel Med 2021; 28:1-8. This recent study evaluates risk factors for AMR bacterial acquisition in a military cohort traveling abroad; they find that ESBL-PE acquisition is highest in South Asia, but overall risk is lower than in civilian populations. This recent study analyses data from 370 Finnish travelers from the 2008 to 2010 prospective study. They determine that most cases of travelers' diarrhea resolve without antimicrobial treatment, highlighting that antimicrobials are overprescribed for this purpose. 56.

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Tackling drug-resistant infections globally: final report and recommendations

Antimicrobial resistance: global report on surveillance. World Health Organization 2014

Transfer of multidrug-resistant bacteria between intermingled ecological niches: the interface between humans, animals and the environment

High levels of antibiotic resistance in isolates from diseased livestock

Distribution of genetic elements associated with antibiotic resistance in treated and untreated animal husbandry waste and wastewater

Global trends in antimicrobial use in aquaculture

Occurrence and characteristics of mobile colistin resistance (Mcr) gene-containing isolates from the environment: a review

Encouraging AWaRe-ness and discouraging inappropriate antibiotic use: the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool

Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries

Continuous evolution: perspective on the epidemiology of carbapenemase resistance among enterobacterales and other Gram-negative bacteria

Critical orientation in the jungle of currently available methods and types of data for source attribution of foodborne diseases

A survey of sub-inhibitory concentrations of antibiotics in the environment

Antimicrobial pharmaceuticals in the aquatic environment: occurrence and environmental implications

Seasonal variations in export of antibiotic resistance genes and bacteria in runoff from an agricultural watershed in Iowa

Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study

Quinolones: mechanism, lethality and their contributions to antibiotic resistance

Fecal colonization with extendedspectrum beta-lactamase-producing enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis

Audacious Hitchhikers: the role of travel and the International Food Trade in the global dissemination of mobile colistin-resistance (mcr) genes

ESBL-producing strains isolated from imported cases of enteric fever in England and Wales reveal multiple chromosomal integrations of blaCTX-M-15 in XDR Salmonella Typhi

This recent study investigates cases of imported enteric fever in the UK resulting from travel; all isolates of S. Typhi and Paratyphi were ESBL-producing and primarily associated with travel to South Asia

Continued outbreak of ceftriaxoneresistant Salmonella enterica serotype Typhi across Pakistan and assessment of knowledge and practices among healthcare workers

Emergence of an extensively drugresistant Salmonella enterica serovar typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins

Antimicrobial resistance and COVID-19: Intersections and implications

A multifactorial approach for surveillance of Shigella spp. and entero-invasive Escherichia coli is important for detecting (Inter)national clusters

This study applies multiple strategies to Shigella and EIEC surveillance for the detection of related clusters, and they find that there are overlaps in travel-related and domestic clusters in the Netherlands, suggesting secondary transmission

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

Genomic insights into the emergenceand spread of antimicrobial-resistantbacterial pathogens

NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases

The characteristics of NDMproducing Klebsiella pneumoniae from Canada

New Delhi metallo-betalactamase 1-producing Enterobacteriaceae: emergence and response in Europe

Global spread of antibiotic resistance: the example of New Delhi metallo-b-lactamase (NDM)-mediated carbapenem resistance

Global spread of New Delhi metallo-b-lactamase 1

Detection of the plasmid-mediated colistin-resistance gene mcr-1 in faecal metagenomes of Dutch travellers

First case of New Delhi metallob-lactamase in Klebsiella pneumoniae from Ecuador: an update for South America

Carriage of colistin-resistant, extended-spectrum b-lactamase-producing escherichia coli harboring the mcr-1 resistance gene after short-term international travel to Vietnam

mcr-1-positive colistin-resistant Escherichia coli in traveler returning to Canada from China

Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study

Emergence of almost identical f36:A-:B32 plasmids carrying blandm-5 and qepa in escherichia coli from both Pakistan and Canada

GeoSentinel: past, present and futurey

National antimicrobial resistance monitoring system: two decades of advancing public health through integrated surveillance of antimicrobial resistance

Visualizing variation within global pneumococcal sequence clusters (GPSCS) and country population snapshots to contextualize pneumococcal isolates

Rapid identification, capsular typing and molecular characterization of Streptococcus pneumoniae by using whole genome nanopore sequencing

Positive result of Sars-Cov-2 in faeces and sputum from discharged patients with COVID-19 in Yiwu

SARS-CoV-2 from faeces to wastewater treatment: what do we know? A review

Monitoring SARS-CoV-2 circulation and diversity through community wastewater sequencing, the Netherlands and Belgium

Role of gut microbiota in travel-related acquisition of extended spectrum b-lactamase-producing Enterobacteriaceae

This recent study profiles the gut microbiota of a Hong Kong cohort of international travelers using 16S rDNA amplicon sequencing, finding that Actinobacteria richness pretravel is a risk factor for ESBL-PE acquisition

Stand-by antibiotics encourage unwarranted use of antibiotics for travelers' diarrhea: a prospective study

Acquisition of plasmid-mediated cephalosporinase producing Enterobacteriaceae after a travel to the tropics